Back

Ultragenyx Pharmaceutical Quote, Financials, Valuation and Earnings

America's Final Republican President

Click here to see his 2024 election prediction.

Sell

RARE
Ultragenyx Pharmaceutical

Last Price:

43.27

Seasonality Move:

12.66%

7 Day Trial

ALL ACCESS PASS

$ 7

7 Powerhouse Stocks to Buy and Hold Forever

Get it now.

Ultragenyx Pharmaceutical Price Quote

$43.27

+0.74 (+1.74%)

(Updated: May 1, 2024 at 6:55 PM ET)

Ultragenyx Pharmaceutical Key Stats

Sell

Ultragenyx Pharmaceutical (RARE) is a Sell

Day range:

$42.51 - $44.32

52-week range:

$31.52 - $54.98

Dividend yield:

P/E ratio:

0.00

P/S ratio:

7.20

P/B ratio:

12.71%

Volume:

547.4K

Avg. volume:

663.4K

1-year change:

-2.61%

Market cap:

$3.5B

Revenue:

$434.2M

EPS:

$-8.33

How Much Does Ultragenyx Pharmaceutical Make?

How Much Are Ultragenyx Pharmaceutical's Sales Annually?
RARE Revenues are $434.2M
How Much Profit Does Ultragenyx Pharmaceutical's Make A Year?
RARE net income is -$606.6M

Is Ultragenyx Pharmaceutical Growing As A Company?

What Is Ultragenyx Pharmaceutical's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.23%
What Is Ultragenyx Pharmaceutical's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%

Ultragenyx Pharmaceutical Stock Price Performance

Did Ultragenyx Pharmaceutical Stock Go Up Last Month?
Ultragenyx Pharmaceutical share price went down by -8.91% last month
Did RARE's Share Price Rise Over The Last Year?
RARE share price fell by -2.61% over the past 1 year

What Is Ultragenyx Pharmaceutical 52-Week High & Low?

What Is Ultragenyx Pharmaceutical’s 52-Week High Share Price?
Ultragenyx Pharmaceutical has traded as high as $54.98 over the past 52 weeks
What Is Ultragenyx Pharmaceutical’s 52-Week Low Share Price?
Ultragenyx Pharmaceutical has traded as low as $31.52 over the past 52 weeks

Ultragenyx Pharmaceutical Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Ultragenyx Pharmaceutical?

How Much Debt Does Ultragenyx Pharmaceutical Have?
Total long term debt quarterly is $0
How Much Cash Does Ultragenyx Pharmaceutical Have?
Cash and short term investments quarterly total is $577.2M
What Is Ultragenyx Pharmaceutical’s Book Value Per Share?
Book value per share is 3.35

Is Ultragenyx Pharmaceutical Cash Flow Positive?

What Is RARE Cash Flow From Operations?
Cash flow from operations (TTM) is -$474.8M
What Is Ultragenyx Pharmaceutical’s Cash Flow From Financing?
Cash flow from financing (TTM) is $388.1M
What Is Ultragenyx Pharmaceutical’s Cash Flow From Investing?
Cash flow from investing (TTM) is $168M

Ultragenyx Pharmaceutical Return On Invested Capital

Is Management Doing A Good Job?
RARE return on invested capital is -300.57%
What Is Ultragenyx Pharmaceutical Return On Assets?
ROA measures how assets are converting to revenues and is -43.52%
What Is RARE Return On Equity?
ROE is a measure of profitability and is -300.57%

Ultragenyx Pharmaceutical Earnings Date & Stock Price

What Is Ultragenyx Pharmaceutical's Stock Price Today?
A single share of RARE can be purchased today for 42.53
What Is Ultragenyx Pharmaceutical’s Stock Symbol?
Ultragenyx Pharmaceutical trades on the nasdaq under the ticker symbol: RARE
When Is Ultragenyx Pharmaceutical’s Next Earnings Date?
The next quarterly earnings date for Ultragenyx Pharmaceutical is scheduled on May 2, 2024
When Is RARE's next ex-dividend date?
Ultragenyx Pharmaceutical's next ex-dividend date is May 27, 2020
How To Buy Ultragenyx Pharmaceutical Stock?
You can buy Ultragenyx Pharmaceutical shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Ultragenyx Pharmaceutical Competitors

Who Are Ultragenyx Pharmaceutical's Competitors?
Below is a list of companies who compete with Ultragenyx Pharmaceutical or are related in some way:
- Corcept Therapeutics Inc (CORT)
- FibroGen Inc (FGEN)
- Madrigal Pharmaceuticals Inc (MDGL)
- Rocket Pharmaceuticals Inc (RCKT)
- Sarepta Therapeutics Inc (SRPT)

Ultragenyx Pharmaceutical Dividend Yield